Direct-acting antivirals
61 articles
People Who Inject Drugs Report Unique Barriers to Hepatitis C Treatment
A Toronto study analyzes differences in hepatitis C treatment experiences based on drug use. More
Self-Reported and Objective Compliance for HCV Treatment Reflect Different Cure Rates
Study exposes the adherence gap in HCV direct-acting antiviral therapy among people who inject drugs. More
Telemedicine at Syringe Access Programs May Address Barriers, Expand Access to HCV Treatment
A survey found telemedicine-based HCV treatment at a syringe access program could improve access to treatment among people who inject drugs. More
Rapid Communication: Co-Administration of Treatment for Drug-Resistant TB and Hepatitis C
WHO announces forthcoming updates on co-administration of treatment for drug-resistant TB and hepatitis C. More
Medicines for HIV, Viral Hepatitis, and STIs in LMICs: Forecasts of Global Demand for 2022-2026
WHO releases a report jointly presenting medicines forecasts across three disease areas in recognition of the benefits of addressing HIV, viral hepatitis and STIs in a coordinated manner. More
